The aims of this protocol are: 1) to determine the kinetics of LDL- and HDL-cholesterol particles in nephrotic syndrome subjects. This will be accomplished using stable isotopic tracers to label and characterize the plasma disappearance of apolipoprotein B-100 (LDL) and apolipoprotein A-1 (HDL) in 6 subjects with nephrotic syndrome following either olive oil (control) or fish oil therapy. 2) to assess eicosanoid metabolites in patients with nephrotic syndrome.
Showing the most recent 10 out of 423 publications